The DNM1 gene helps nerve cells recycle the tiny sacs that release chemical messages, which keeps brain signaling going. This gene plays an important role in communication between nerve cells, and if it does not work properly, signaling can be disrupted. Pathogenic variants in the DNM1 gene are linked to a form of developmental and epileptic encephalopathy, often with early seizures, developmental delay, low muscle tone, and movement differences. The DNM1 gene is mainly known in neurology and genetics rather than through celebrity or media attention.
What is a gene?
Genes are stretches of DNA that hold instructions cells use to make molecules or regulate processes in the body. In some genes, these instructions are for making proteins, the parts of cells that do much of the work. Other genes mainly direct when certain processes happen, where they happen, and how active they are. Together, genes affect how the body develops and functions, and they can also influence how you respond to food, stress, or medications. For a deeper look at this topic, you can learn more in LearnHub.
Overview
DNM1Gene function
What if the gene works
The DNM1 gene helps nerve cells recycle the tiny sacs that release chemical messages. This supports steady communication between brain cells, especially during rapid signaling.
Risk
What if the gene does not work
Variants in the DNM1 gene can disrupt signaling between nerve cells, often leading to seizures starting in infancy, developmental delay, and sometimes movement problems; milder and more severe variants may affect when symptoms begin and how strongly they appear.
Treatment
What does that mean for your treatment
For a pathogenic or loss-of-function variant in the DNM1 gene, no DNM1-specific treatment or management approach is currently established, so drug choices are usually based on the person’s symptoms rather than the variant itself.
Conditions associated with DNM1
Gene function
What if the gene works
Nerve cells need a fast way to reuse the tiny sacs that carry chemical messages. The DNM1 gene supports this recycling process, especially in the brain. Its protein helps pinch used membrane into new vesicles so signals can keep moving. This helps explain how the DNM1 gene works in nerve cells during everyday brain signaling.
The DNM1 gene helps nerve cells remake tiny sacs called vesicles after they release a signal. This lets membrane and messenger supplies be reused for the next round of cell communication.
Its protein forms a tightening ring around a small patch of cell membrane. Using energy from GTP, a cell fuel, it pinches that piece free to create a new vesicle.
Many neurons send messages again and again, so they need quick vesicle turnover. By supporting this step, the DNM1 gene helps nerve cell signaling stay steady and responsive.
This gene also supports endocytosis, the normal process cells use to bring membrane material inward. This helps nerve cells maintain their surface and recycle parts they use every day.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human differences, including appearance, metabolism, and the way the body responds to environmental influences. Many variants do not have any noticeable effect and are simply part of natural genetic variation. At times, though, a variant can more significantly change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the DNM1 gene can change the shape of dynamin-1, making it less stable, less active, or unable to assemble correctly with other copies of the protein. Some DNM1 gene variant effects are mild and partly reduce function, while more disruptive variants can strongly block synaptic vesicle recycling in nerve cells. Certain variants also act in a dominant-negative way (the altered protein interferes with the usual protein), which often leads to earlier and more pronounced developmental and seizure-related features.
How variants are linked to conditions
Pathogenic variants in the DNM1 gene can cause developmental and epileptic encephalopathy, a condition in which DNM1 gene variants are linked to early seizures and developmental delay. Many children with this diagnosis also have intellectual disability, low muscle tone, or movement differences. Some people carrying a DNM1 gene variant have developmental difficulties with fewer or no seizures, so the condition can look different from one person to another.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are widely found in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For DNM1, risk is usually driven mainly by the gene change itself rather than by lifestyle or everyday exposures. In most families, a DNM1 change happens for the first time in the child, but family history can matter in some cases, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of DNM1 variants
Most established DNM1-related conditions follow an autosomal dominant pattern, which means one altered copy of the DNM1 gene can be enough to cause the condition. In families, the DNM1 inheritance pattern means a parent carrying a disease-causing variant has a 50% chance of passing it to each child. Many affected children have a new, de novo variant in the DNM1 gene, so the change was not inherited from either parent.
What does my DNM1 result mean for my family?
For DNM1, family impact usually depends on a dominant pattern. A parent, brother, sister, or child may also carry the same change, so close relatives may want to discuss family testing. Many living with a DNM1-related condition have a new gene change that was not inherited from either parent, so this result does not always mean a parent has it.
Genetic information
Genetic testing
How you find out about variants
Doctors find DNM1 variants with genetic testing, usually by reading DNA from a blood or saliva sample. DNM1 genetic testing may be done in a seizure gene panel or a broader DNA test, and the result may show a disease causing variant, a harmless variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider testing if a child has seizures starting in infancy, repeated unexplained seizures, or major developmental delays, especially with a family history of similar problems. A DNM1 variant can help explain the cause and confirm a genetic diagnosis in some families.
A genetic result is only one part of your health story
A genetic result can be informative, but what it reveals depends on the condition in question and the kind of variant involved. Many other influences, including lifestyle, environment, age, and medical history, shape how the body works over time. In some conditions, especially those affected by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body absorbs, breaks down, moves, or responds to a drug, so the same treatment may work well for one person but less well for another. This kind of variation is common and can influence both how much benefit someone gets from a medicine and how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics explores how differences in genes can affect a person’s response to medications. It examines relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence both how strongly a drug works and how the body handles it. This information can support more informed, individualized treatment choices. You can read more about this topic in the LearnHub.
Drugs influenced by the DNM1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting medicine response, so questions about treatment benefits, side effects, or changes in seizure control are best discussed with your doctor.
History
Researchers identified the DNM1 gene during work in the late 1980s and early 1990s on proteins involved in nerve cell signaling. Early studies linked dynamin proteins to the rapid recycling system nerve endings use after sending messages, which made DNM1 important in neuroscience research. From these first observations, research expanded steadily. As genetic testing became more widely used, variants in the DNM1 gene were recognized as a cause of some forms of developmental and epileptic encephalopathy, helping connect laboratory findings with patient care. That shift marked an important step in showing how basic brain research can lead to clearer genetic diagnoses.